Firm may have blood test to determine presence of Alzheimer's

03/15/2007 | Yahoo!

France's ExonHit Therapeutics says it has identified a set of genes that may allow it to analyze blood samples to determine if a patient has Alzheimer's disease. In one study involving a group of 85 people, the firm said, the process was able to identify 78% of the people with Alzheimer's and 82% of those without it.

View Full Article in:

Yahoo!

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Claims Director
PacificSource
Springfield, OR
Consultant
Attest Health Care Advisors
Nationwide, SL_Nationwide
Biotechnology/Pharmaceutical Patent Attorney
Coats and Bennett PLLC
Cary, NC
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA